Provided by Tiger Fintech (Singapore) Pte. Ltd.

BioNexus Gene Lab Corp.

3.10
-0.1200-3.73%
Post-market: 3.170.0700+2.26%19:31 EDT
Volume:46.83K
Turnover:146.54K
Market Cap:5.57M
PE:-5.85
High:3.21
Open:3.12
Low:3.00
Close:3.22
Loading ...
Aug 26, 2024

Major Issues Report

Form 8-K - Current report
Aug 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 05, 2024

Major Issues Report

Form 8-K/A - Current report: [Amend]
May 31, 2024

[Rev.]Annual Report

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
May 31, 2024

[Rev.]Quaterly Report

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
May 31, 2024

[Rev.]Annual Report

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
May 31, 2024

[Rev.]Quaterly Report

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
May 31, 2024

[Rev.]Quaterly Report

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
May 24, 2024

Correspondence

Form CORRESP - Correspondence
May 15, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 09, 2024

Major Issues Report

Form 8-K - Current report
Apr 18, 2024

Major Issues Report

Form 8-K - Current report
Apr 16, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Apr 01, 2024

Major Issues Report

Form 8-K - Current report
Mar 26, 2024

[Rev.]Quaterly Report

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
Jan 23, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 17, 2024

Beneficial Ownership Change

Form SC 13D - General statement of acquisition of beneficial ownership
Nov 20, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 14, 2023

Major Issues Report

Form 8-K - Current report
Nov 03, 2023

Major Issues Report

Form 8-K - Current report